Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects.
about
Primary hypercholesterolemia: genetic causes and treatment of five monogenic disorders.Mutations and polymorphisms in the proprotein convertase subtilisin kexin 9 (PCSK9) gene in cholesterol metabolism and disease.Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: efficacy and tolerability.Mutation detection rate and spectrum in familial hypercholesterolaemia patients in the UK pilot cascade project
P2860
Autosomal dominant type IIa hypercholesterolemia: evaluation of the respective contributions of LDLR and APOB gene defects as well as a third major group of defects.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Autosomal dominant type IIa hy ...... third major group of defects.
@en
Autosomal dominant type IIa hy ...... third major group of defects.
@nl
type
label
Autosomal dominant type IIa hy ...... third major group of defects.
@en
Autosomal dominant type IIa hy ...... third major group of defects.
@nl
prefLabel
Autosomal dominant type IIa hy ...... third major group of defects.
@en
Autosomal dominant type IIa hy ...... third major group of defects.
@nl
P2093
P50
P356
P1476
Autosomal dominant type IIa hy ...... a third major group of defects
@en
P2093
Blanchard P
Bonaïti-Péllié C
Devillers M
P2888
P304
P356
10.1038/SJ.EJHG.5200516
P577
2000-08-01T00:00:00Z